Quantcast

Latest autoimmune diseases Stories

2014-09-29 16:25:44

ORLANDO, Fla. and DUBLIN, Sept. 29, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company"), a biotechnology company pioneering the manufacturing both US and Internationally as well as the marketing of innovative therapies for cancer, HIV/AIDS, opportunistic infections and autoimmune diseases in emerging nations, issued a letter to its shareholders from CEO Noreen Griffin The letter follows: Dear Shareholders, TNI BioTech, Inc. (the "Company" or "TNIB")...

2014-09-26 08:25:39

Comedian Jo Koy will serve as Walk Ambassador for San Francisco's Walk to End Lupus Now on October 26th WASHINGTON, Sept. 26, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America will host its annual Walk To End Lupus Now(TM )event in San Francisco on Sunday, October 26, 2014 at Golden Gate Park. Walk Ambassador, comedian Jo Koy, will join thousands of San Francisco residents to raise money for lupus research and education programs, increase awareness of the disease, and...

2014-09-25 08:27:15

SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- Meritage Pharma, Inc. announced today positive Phase 2b results of oral budesonide suspension (OBS) for the treatment of adolescents and adults with eosinophilic esophagitis (EoE), a chronic disease characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation. OBS achieved the co-primary endpoints of reduction in inflammation (p< 0.0001) and symptom of dysphagia (p=0.0096) with statistical...

2014-09-25 08:27:02

-- HUMIRA is now indicated to treat pediatric patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate NORTH CHICAGO, Ill., Sept. 25, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that the U.S. Food and Drug Administration (FDA) has approved HUMIRA(®) (adalimumab) for reducing signs and symptoms, and achieving and...

2014-09-24 16:26:20

DANVERS, Mass., Sept. 24, 2014 /PRNewswire-USNewswire/ -- The Scleroderma Foundation's national Board of Directors approved today a merger of two Southern California chapters. The Southern California Chapter and the Greater San Diego Chapter proposed the merger as a way to enhance support and education services to its constituents. The merged chapters will operate under the name of the Scleroderma Foundation of Southern California to advance the mission of education, support and...

2014-09-23 16:27:26

ORLANDO, Fla. and DUBLIN, Sept. 23, 2014 /PRNewswire/ --TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company"), a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced that the Depository Trust Company ("DTC") has approved our common stock for DTC's Deposit and Withdrawal at Custodian ("DWAC") service using a Fast Automated Securities Transfer Service ("FAST") transfer agent as the...

2014-09-23 08:30:57

Be Joint Smart to educate roughly 150,000 local residents with PsA about their disease PORTLAND, Ore., Sept. 23, 2014 /PRNewswire-USNewswire/ -- If you're one of the roughly 150,000 NY Metro residents struggling with pain from psoriatic arthritis (PsA)--an inflammatory autoimmune disease that causes pain, swelling and stiffness of the joints and tendons--learn to control your condition with Be Joint Smart, a free psoriatic arthritis program presented by the National Psoriasis Foundation, at...

2014-09-22 12:26:11

More than $300,000 raised to support research, education and support services for people affected by lupus LOS ANGELES, Sept. 22, 2014 /PRNewswire-USNewswire/ -- Hollywood stars of television turned out to shed light on the cruel mystery that is lupus and raise critically needed funds for research and education programs during the Lupus Foundation of America's (LFA) Walk to End Lupus Now(TM), in Los Angeles on Saturday, September 20, 2014. Walk to End Lupus Now Grand Marshal,...

2014-09-22 08:28:00

Companies Include Silarus Therapeutics Developing Treatments for Anemia and Iron Overload Disorders; and Thyritope Biosciences Developing Treatments for Graves' Orbitopathy SAN DIEGO, Sept. 22, 2014 /PRNewswire/ -- Avalon Ventures today announced the launch of two new companies formed through its collaboration with GlaxoSmithKline (GSK) to fund and launch up to 10 early-stage life science companies. Silarus Therapeutics, Inc. and Thyritope Biosciences, Inc. each will receive up to...

2014-09-22 08:26:16

TOORAK, Australia, Sept. 22, 2014 /PRNewswire/ -- Antisense Therapeutics (the "Company" or "ANP") is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology. The article titled "CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS", is currently available online and will be included in the print edition Volume 83, November 11, 2014. The article highlights the...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'